167 related articles for article (PubMed ID: 16830805)
1. [Development of drug coating on drug eluting stents].
Luo LL; Wang GX; Yin TY
Zhongguo Yi Liao Qi Xie Za Zhi; 2006 Mar; 30(2):117-9. PubMed ID: 16830805
[TBL] [Abstract][Full Text] [Related]
2. Drug-eluting stents.
García-García HM; Vaina S; Tsuchida K; Serruys PW
Arch Cardiol Mex; 2006; 76(3):297-319. PubMed ID: 17091802
[TBL] [Abstract][Full Text] [Related]
3. Polymer coating techniques for drug-eluting stents.
al-Lamee K; Cook D
Med Device Technol; 2003; 14(1):12-4. PubMed ID: 12974119
[TBL] [Abstract][Full Text] [Related]
4. Drug-eluting stents: role of stent design, delivery vehicle, and drug selection.
Rodgers CD
Rev Cardiovasc Med; 2002; 3 Suppl 5():S10-5. PubMed ID: 12478230
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and safety of the sirolimus-eluting stents coated with bioabsorbable polymer coating in human coronary arteries.
Ge J; Qian J; Wang X; Wang Q; Yan W; Yan Y; Fan B; Ge L; Liu X
Catheter Cardiovasc Interv; 2007 Feb; 69(2):198-202. PubMed ID: 17195205
[TBL] [Abstract][Full Text] [Related]
6. Improved blood compatibility of rapamycin-eluting stent by incorporating curcumin.
Pan CJ; Tang JJ; Shao ZY; Wang J; Huang N
Colloids Surf B Biointerfaces; 2007 Sep; 59(1):105-11. PubMed ID: 17540543
[TBL] [Abstract][Full Text] [Related]
7. Release profiles in drug-eluting stents: issues and uncertainties.
Venkatraman S; Boey F
J Control Release; 2007 Jul; 120(3):149-60. PubMed ID: 17582635
[TBL] [Abstract][Full Text] [Related]
8. Role of stent design and coatings on restenosis and thrombosis.
Hara H; Nakamura M; Palmaz JC; Schwartz RS
Adv Drug Deliv Rev; 2006 Jun; 58(3):377-86. PubMed ID: 16650911
[TBL] [Abstract][Full Text] [Related]
9. The short-term effects on restenosis and thrombosis of echinomycin-eluting stents topcoated with a hydrophobic heparin-containing polymer.
Lee YK; Hyung Park J; Tae Moon H; Yun Lee D; Han Yun J; Byun Y
Biomaterials; 2007 Mar; 28(8):1523-30. PubMed ID: 17157376
[TBL] [Abstract][Full Text] [Related]
10. Biodegradable coating for drug-eluting stents--more than a facelift?
Niemelä KO
Eur Heart J; 2008 Aug; 29(16):1930-1. PubMed ID: 18586664
[No Abstract] [Full Text] [Related]
11. Preparation and in vitro release profiles of drug-eluting controlled biodegradable polymer coating stents.
Pan CJ; Tang JJ; Weng YJ; Wang J; Huang N
Colloids Surf B Biointerfaces; 2009 Oct; 73(2):199-206. PubMed ID: 19541460
[TBL] [Abstract][Full Text] [Related]
12. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
Richard R; Schwarz M; Chan K; Teigen N; Boden M
J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
[TBL] [Abstract][Full Text] [Related]
13. [Drug-eluting or bare-metal stents in interventional cardiology. Theory and practice].
Er F; Erdmann E
Med Klin (Munich); 2007 Jan; 102(1):30-2. PubMed ID: 17221349
[TBL] [Abstract][Full Text] [Related]
14. Acrylic copolymers as candidates for drug-eluting coating of vascular stents.
Silvestri D; Cristallini C; Gagliardi M; Barbani N; D'Acunto M; Ciardelli G; Giusti P
J Biomater Appl; 2009 Nov; 24(4):353-83. PubMed ID: 19033328
[TBL] [Abstract][Full Text] [Related]
15. A mathematical model for predicting drug release from a biodurable drug-eluting stent coating.
Hossainy S; Prabhu S
J Biomed Mater Res A; 2008 Nov; 87(2):487-93. PubMed ID: 18186043
[TBL] [Abstract][Full Text] [Related]
16. Optimal stent design for drug delivery.
Rogers CD
Rev Cardiovasc Med; 2004; 5 Suppl 2():S9-S15. PubMed ID: 15184829
[TBL] [Abstract][Full Text] [Related]
17. [Progress on reasech of drug-coated stent].
Zhang L; Liu J
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Feb; 24(1):235-9. PubMed ID: 17333930
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting stents.
Med Lett Drugs Ther; 2003 Mar; 45(1152):23-4. PubMed ID: 12637894
[No Abstract] [Full Text] [Related]
19. Novel polymeric coatings with the potential to control in-stent restenosis--an in vitro study.
Nickson CM; Doherty PJ; Williams RL
J Biomater Appl; 2010 Jan; 24(5):437-52. PubMed ID: 19033327
[TBL] [Abstract][Full Text] [Related]
20. Tetramethylpyrazine-eluting stents prevented in-stent restenosis in a porcine model.
Ma G; Ding S; Feng Y; Shen C; Chen L; Chen Z
J Cardiovasc Pharmacol; 2007 Aug; 50(2):201-5. PubMed ID: 17703137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
